Literature DB >> 11238162

Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.

M Lièvre1, J Ménard, E Bruckert, J Cogneau, F Delahaye, P Giral, E Leitersdorf, G Luc, L Masana, P Moulin, P Passa, D Pouchain, G Siest.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2001        PMID： 11238162      PMCID： PMC1119794          DOI： 10.1136/bmj.322.7286.603

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  What is the optimal age for starting lipid lowering treatment? A mathematical model.

Authors:  S Ulrich; A D Hingorani; J Martin; P Vallance
Journal:  BMJ       Date:  2000-04-22

2.  AIDS, ethics, and clinical trials. Institute of Medical Ethics Working Party on the Ethical Implications of AIDS.

Authors: 
Journal:  BMJ       Date:  1992-09-19

3.  Statins and coronary heart disease.

Authors:  R Fey; N Pearson
Journal:  Lancet       Date:  1996-05-18       Impact factor: 79.321

4.  The emerging role of statins in the prevention of coronary heart disease.

Authors:  M F Muldoon; M H Criqui
Journal:  BMJ       Date:  1997-12-13

5.  A curious stopping rule from Hoechst Marion Roussel.

Authors: 
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

6.  Early closure of European Pimagedine trial. Steering Committee. Safety Committee.

Authors:  G Viberti; G Slama; G Pozza; A Czyzyk; R W Bilous; A Gries; H Keen; J H Fuller; G Menzinger
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

7.  Early stopping of trials.

Authors:  G Hopf
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

8.  Early stopping of trials.

Authors:  A Langer
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
  10 in total
  21 in total

1.  Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.

Authors:  S Evans; S Pocock
Journal:  BMJ       Date:  2001-03-10

2.  Responsibilities of sponsors are limited in premature discontinuation of trials.

Authors:  R Ashcroft
Journal:  BMJ       Date:  2001-07-07

3.  Clinical research: a European Union Directive.

Authors:  F Lemaire; An Johana Baeyens
Journal:  Intensive Care Med       Date:  2002-04-12       Impact factor: 17.440

4.  Editorial: No-difference Studies Make a Big Difference.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2015-09-01       Impact factor: 4.176

Review 5.  Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature.

Authors:  Chris S Bailey; Michael G Fehlings; Y Raja Rampersaud; Hamilton Hall; Eugene K Wai; Charles G Fisher
Journal:  Can J Surg       Date:  2011-10       Impact factor: 2.089

Review 6.  Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.

Authors:  A S Iltis
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

7.  Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?

Authors:  Peter B Berger; Judson B Williams; Vic Hasselblad; Karen Chiswell; Karen S Pieper; Robert M Califf
Journal:  J Interv Cardiol       Date:  2013-02-05       Impact factor: 2.279

8.  Institutional ethics review of clinical study agreements.

Authors:  G DuVal
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

9.  "One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa.

Authors:  Mitzy Gafos; Misiwe Mzimela; Hlengiwe Ndlovu; Nkosinathi Mhlongo; Yael Hoogland; Richard Mutemwa
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

10.  17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.

Authors:  C Andrew Combs; Thomas J Garite; Kimberly Maurel; Kimberly Mallory; Rodney K Edwards; George Lu; Richard Porreco; Anita Das
Journal:  BMC Res Notes       Date:  2011-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.